CTOs on the Move

SpineGuard

www.spineguard.com

 
Founded in 2009 in France and the USA by Pierre Jerome and Stephane Bette, SpineGuard is an innovative company deploying its proprietary radiation-free real time sensing technology DSG® (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. SpineGuard designs, develops and markets medical devices that have been used in over 80,000 surgical procedures worldwide. Sixteen studies published in peer-reviewed scientific journals have demonstrated the multiple benefits DSG® offers to patients, surgeons, surgical staff and hospitals. Building on these solid fundamentals and several strategic partnerships, SpineGuard has expanded its technology platform in a disruptive innovation: the ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.spineguard.com
  • 1434 Spruce Street Suite 100
    Boulder, CO USA 80302
  • Phone: 720.726.8085

Executives

Name Title Contact Details

Similar Companies

Auto-rain Supply

Auto-rain Supply is a Spokane, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Aria CV

Aria CV, Inc: Improving the lives of patients suffering from the disease of pulmonary hypertension.

fast response safety training

fast response safety training is a Berkeley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Convergent Laser Technologies

Convergent Laser Technologies is a Alameda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Seno Medical Instruments

Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno`s Imagio breast imaging system fuses opto-acoustic technology with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map in and around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that the Imagio OA breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents.